These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8666216)

  • 21. Fluoxetine treatment of depressed patients with HIV infection.
    Judd FK; Mijch AM; Cockram A
    Aust N Z J Psychiatry; 1995 Sep; 29(3):433-6. PubMed ID: 8573046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse events and tolerability of the combination of fluoxetine/lithium compared with fluoxetine.
    Bauer M; Linden M; Schaaf B; Weber HJ
    J Clin Psychopharmacol; 1996 Apr; 16(2):130-4. PubMed ID: 8690828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unsuspected poor metabolizer phenotypes of fluoxetine in bioavailability/bioequivalence studies from an indian population perspective. Retrospective pharmacokinetic data evaluation.
    Kandasamy M; Tripathy K; Ravi S; Kamath N; Pai B; Srinivas NR; Kristjansson F; Thangam S
    Arzneimittelforschung; 2010; 60(1):12-21. PubMed ID: 20184222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma free 3-methoxy-4-hydroxyphenylglycol predicts response to fluoxetine.
    Ko HC; Lu RB; Shiah IS; Hwang CC
    Biol Psychiatry; 1997 Apr; 41(7):774-81. PubMed ID: 9084896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression.
    Dam J; Ryde L; Svejsø J; Lauge N; Lauritsen B; Bech P
    Pharmacopsychiatry; 1998 Mar; 31(2):48-54. PubMed ID: 9562208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder.
    Baker B; Dorian P; Sandor P; Shapiro C; Schell C; Mitchell J; Irvine MJ
    J Clin Psychopharmacol; 1997 Feb; 17(1):15-21. PubMed ID: 9004052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of fluoxetine in pregnant baboons (Papio spp.).
    Shoulson RL; Stark RL; Garland M
    J Am Assoc Lab Anim Sci; 2014 Nov; 53(6):708-16. PubMed ID: 25650979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression?
    Smith WT; Londborg PD; Glaudin V; Painter JR;
    J Affect Disord; 2002 Aug; 70(3):251-9. PubMed ID: 12128237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Faster response in depressive patients treated with fluoxetine alone than in combination with buspirone.
    Onder E; Tural U
    J Affect Disord; 2003 Sep; 76(1-3):223-7. PubMed ID: 12943952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
    Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
    CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of depression and anxiety in infertile women: cognitive behavioral therapy versus fluoxetine.
    Faramarzi M; Alipor A; Esmaelzadeh S; Kheirkhah F; Poladi K; Pash H
    J Affect Disord; 2008 May; 108(1-2):159-64. PubMed ID: 17936366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prozac: pros and cons.
    Glod C
    J Psychosoc Nurs Ment Health Serv; 1990 Dec; 28(12):33-4. PubMed ID: 2283599
    [No Abstract]   [Full Text] [Related]  

  • 33. Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression.
    Ramasubbu R
    J Psychiatry Neurosci; 1999 Jan; 24(1):45-50. PubMed ID: 9987207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between antidepressant response and plasma concentrations of fluoxetine and norfluoxetine.
    Norman TR; Gupta RK; Burrows GD; Parker G; Judd FK
    Int Clin Psychopharmacol; 1993; 8(1):25-9. PubMed ID: 8473717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
    Trivedi MH; Thase ME; Osuntokun O; Henley DB; Case M; Watson SB; Campbell GM; Corya SA
    J Clin Psychiatry; 2009 Mar; 70(3):387-96. PubMed ID: 19284928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers.
    Covi L; Hess JM; Kreiter NA; Haertzen CA
    Am J Drug Alcohol Abuse; 1995 Aug; 21(3):327-44. PubMed ID: 7484983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.
    Joyce PR; Mulder RT; Luty SE; Sullivan PF; McKenzie JM; Abbott RM; Stevens IF
    Aust N Z J Psychiatry; 2002 Jun; 36(3):384-91. PubMed ID: 12060188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poststroke depression: psychopharmacological considerations.
    Antai-Otong D
    Perspect Psychiatr Care; 2004; 40(4):167-70. PubMed ID: 15739758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression.
    Rudolph RL; Feiger AD
    J Affect Disord; 1999 Dec; 56(2-3):171-81. PubMed ID: 10701474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.